Business
Launch of in-house rater training service
Launch of in-house rater training service.
About this update from Cambridge Cognition Holdings Plc
[{"type":"text","content":"\n\n\n \n21 January 2025\n \nCambridge Cognition Holdings plc\n(\"Cambridge Cognition\", the \"Company\" or the \"Group\")\n \nCambridge Cognition expands services with the launch of in-house Rater Training\n \nCambridge Cognition Holdings plc (AIM: COG), the brain health software group specialising in digital products that advance brain health research and treatment, is pleased to announce the launch of its in-house Rater Training service.\nRater training is an important component of successful Central Nervous System (CNS) clinical studies that ensure customers' clinical trial staff collect reliable CNS study data. Adding in-house Rater Training to the Group's electronic Clinical Outcome Assessments (eCOA) and Automated Quality Assurance tools will enable the Company to become a single platform provider and expand the size of the accessible CNS clinical trials market in which its products can be utilised.\n \nThe global cognitive assessment and training healthcare market, encompassing rater training services, delivered revenues of $5.2 billion in 2023 and, notably, the services segment, which includes comprehensive rater training solutions, captured more than 50% of the total market revenue1. This market is projected to grow at a compound annual growth rate of 27% through 20301.\n \nBarbara Enger RN MSN, a CNS expert with 20 years of experience in eCOA service delivery and a consultant for Cambridge Cognition, commented:\n\"Rater training is a critical and mandatory component of successful CNS clinical studies. Raters must demonstrate thorough knowledge of the administration and scoring of the endpoint instrument, and must achieve acceptable levels of both intra rater and inter rater reliability prior to the start of the study and continuing through the length of the study. ...